| Identification of type 2 diabetes subgroups through topological analysis of patient similarity L Li, WY Cheng, BS Glicksberg, O Gottesman, R Tamler, R Chen, ... Science translational medicine 7 (311), 311ra174-311ra174, 2015 | 620 | 2015 |
| Randomized trial of empagliflozin in nondiabetic patients with heart failure and reduced ejection fraction CG Santos-Gallego, AP Vargas-Delgado, JA Requena-Ibanez, ... Journal of the American College of Cardiology 77 (3), 243-255, 2021 | 383 | 2021 |
| An evaluation of diabetes self-management applications for Android smartphones AP Demidowich, K Lu, R Tamler, Z Bloomgarden Journal of telemedicine and telecare 18 (4), 235-238, 2012 | 216 | 2012 |
| Effects of n–3 fatty acids on macro-and microvascular function in subjects with type 2 diabetes mellitus A Stirban, S Nandrean, C Götting, R Tamler, A Pop, M Negrean, ... The American journal of clinical nutrition 91 (3), 808-813, 2010 | 157 | 2010 |
| Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in … A Baum, J Scarpa, E Bruzelius, R Tamler, S Basu, J Faghmous The lancet Diabetes & endocrinology 5 (10), 808-815, 2017 | 129 | 2017 |
| Diabetes, obesity, and erectile dysfunction R Tamler Gender medicine 6, 4-16, 2009 | 95 | 2009 |
| Protection by organotellurium compounds against peroxynitrite-mediated oxidation and nitration reactions K Briviba, R Tamler, LO Klotz, L Engman, IA Cotgreave, H Sies Biochemical pharmacology 55 (6), 817-823, 1998 | 84 | 1998 |
| Rationale and design of the EMPA-TROPISM trial (ATRU-4): are the “cardiac benefits” of empagliflozin independent of its hypoglycemic activity? CG Santos-Gallego, A Garcia-Ropero, D Mancini, SP Pinney, ... Cardiovascular drugs and therapy 33, 87-95, 2019 | 67 | 2019 |
| Sex hormones and bariatric surgery in men SR Rao, S Kini, R Tamler Gender medicine 8 (5), 300-311, 2011 | 51 | 2011 |
| Dietary supplements and nutraceuticals in the management of andrologic disorders R Tamler, JI Mechanick Endocrinology and metabolism clinics of North America 36 (2), 533-552, 2007 | 48 | 2007 |
| Hypogonadism, erectile dysfunction, and type 2 diabetes mellitus: what the clinician needs to know R Tamler, T Deveney Postgraduate medicine 122 (6), 165-175, 2010 | 44 | 2010 |
| Parathyroid carcinoma: ultrasonographic and histologic features R Tamler, MS Lewis, VA LiVolsi, EM Genden Thyroid 15 (7), 744-745, 2005 | 40 | 2005 |
| Nonsteroid immune modulators and bone disease R Tamler, S Epstein Annals of the New York Academy of Sciences 1068 (1), 284-296, 2006 | 36 | 2006 |
| Intensive insulin therapy in the medical ICU. R Tamler, D LeRoith, J Roth The New England journal of medicine 354 (19), 2069-71; author reply 2069, 2006 | 34 | 2006 |
| Hyperglycemia management in patients with posttransplantation diabetes RJ Galindo, M Fried, T Breen, R Tamler Endocrine Practice 22 (4), 454-465, 2016 | 33 | 2016 |
| Comparison of efficacy and safety of glargine and detemir insulin in the management of inpatient hyperglycemia and diabetes RJ Galindo, GM Davis, M Fayfman, D Reyes-Umpierrez, D Alfa, L Peng, ... Endocrine Practice 23 (9), 1059-1066, 2017 | 29 | 2017 |
| Assessment of endothelial function in the patient with erectile dysfunction: an opportunity for the urologist R Tamler, N Bar-Chama International journal of impotence research 20 (4), 370-377, 2008 | 29 | 2008 |
| Effect of case-based training for medical residents on inpatient glycemia R Tamler, DE Green, M Skamagas, TL Breen, HC Looker, M Babyatsky, ... Diabetes Care 34 (8), 1738-1740, 2011 | 26 | 2011 |
| Sex hormone levels in men undergoing bariatric surgery JJ Omana, R Tamler, E Strohmayer, D Herron, S Kini Journal of the American College of Surgeons 209 (3), S22-S23, 2009 | 26 | 2009 |
| EMPA-TROPISM (ATRU-4) Investigators CG Santos-Gallego, AP Vargas-Delgado, JA Requena-Ibanez, ... Randomized trial of empagliflozin in nondiabetic patients with heart failure …, 2021 | 25 | 2021 |
